To Assess the Role of Fecal Microbiota Transplant in Acute Liver Failure
Not Applicable
Withdrawn
- Conditions
- Acute Liver Failure
- Interventions
- Drug: Standard Medical TreatmentOther: Fecal Microbiota TransplantOther: Placebo
- First Posted Date
- 2017-12-05
- Last Posted Date
- 2019-11-05
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Registration Number
- NCT03363022
- Locations
- 🇮🇳
Institute of Liver and Biliary Sciences, New Delhi, Delhi, India
Early Versus Late CRRT in ACLF Patients With Septic Shock and AKI
Not Applicable
- Conditions
- Septic Shock and Acute Kidney Injury
- Interventions
- Other: Late CRRTOther: Early CRRTOther: Standard Medical Therapy
- First Posted Date
- 2017-11-17
- Last Posted Date
- 2017-11-17
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 150
- Registration Number
- NCT03343340
- Locations
- 🇮🇳
Institute of Liver and Biliary Sciences, New Delhi, Delhi, India
Influence of Shunt Occlusion on Organ Functions in Hyperammonemic Patients With Cirrhosis Having Porto-systemic Shunt.
Not Applicable
Completed
- Conditions
- Cirrhosis
- Interventions
- Procedure: Shunt OcclusionDietary Supplement: Standard Medical Treatment (SMT)
- First Posted Date
- 2017-09-26
- Last Posted Date
- 2020-11-17
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 40
- Registration Number
- NCT03293459
- Locations
- 🇮🇳
Institute of Liver and Biliary Sciences, New Delhi, Delhi, India
To Compare TEG (Thrombelastography) and Conventional Tests in CKD Patients
Completed
- Conditions
- CoagulopathyEnd Stage Renal Disease
- Interventions
- Device: Thromboelastography
- First Posted Date
- 2017-09-07
- Last Posted Date
- 2018-06-12
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 100
- Registration Number
- NCT03275077
To Assess the Efficacy of High-Volume Plasma Exchange and GCSF Versus GCSF Alone in Patients of Acute on Chronic Liver Failure (ACLF).
Not Applicable
Withdrawn
- Conditions
- Acute-On-Chronic Liver Failure
- Interventions
- Drug: Standard Medical TherapyBiological: Plasma ExchangeBiological: GCSF
- First Posted Date
- 2017-05-22
- Last Posted Date
- 2018-12-03
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Registration Number
- NCT03162419
- Locations
- 🇮🇳
Institute of Liver and Biliary Sciences, New Delhi, Delhi, India
Frequency of Circulating Tumor Cells (CTCs) and Amount of Cell-free DNA (cfDNA) in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)
Completed
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Other: Cirrhosis with HCCOther: Cirrhosis without HCC
- First Posted Date
- 2017-05-22
- Last Posted Date
- 2019-10-23
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 53
- Registration Number
- NCT03162198
- Locations
- 🇮🇳
Institute of Liver and Biliary Sciences, New Delhi, Delhi, India
To Assess Efficacy of Nutritional Therapy in Secondary Prophylaxis of Hepatic Encephalopathy Versus Lactulose in Patients With Liver Cirrhosis.
Not Applicable
Withdrawn
- Conditions
- Liver Cirrhosis
- Interventions
- First Posted Date
- 2017-05-19
- Last Posted Date
- 2018-12-11
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Registration Number
- NCT03161106
- Locations
- 🇮🇳
Institute of Liver and Biliary Sciences, New Delhi, Delhi, India
The Natural History and Prognostic Factors of Compensated Cirrhosis.
Recruiting
- Conditions
- Compensated Cirrhosis
- First Posted Date
- 2017-05-09
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 166
- Registration Number
- NCT03144700
- Locations
- 🇮🇳
Institute of Liver and Biliary Sciences, New Delhi, Delhi, India
High Versus Low Target Mean Arterial Pressure in Septic Shock in Critically Ill Cirrhotics
Not Applicable
Completed
- Conditions
- Cirrhosis
- Interventions
- Other: Low Target Mean Arterial PressureOther: High Target Mean Arterial Pressure
- First Posted Date
- 2017-05-09
- Last Posted Date
- 2022-09-21
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 150
- Registration Number
- NCT03145168
- Locations
- 🇮🇳
Institute of Liver and Biliary Sciences, New Delhi, Delhi, India
Efficacy and Safety of Terlipressin With Albumin Versus Midodrine With Albumin Versus Albumin Alone in Prevention of Paracentesis Induced Circulatory Dysfunction in Cirrhosis
Not Applicable
Completed
- Conditions
- Cirrhosis
- Interventions
- First Posted Date
- 2017-05-09
- Last Posted Date
- 2018-09-05
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 150
- Registration Number
- NCT03144713
- Locations
- 🇮🇳
Institute of Liver and Biliary Sciences, New Delhi, Delhi, India
© Copyright 2025. All Rights Reserved by MedPath